You are here: Industry Insights > bladder

News List

Less than five per cent of adults with overactive bladder currently treated with drug therapies: GlobalData ExpressPharma
January 06, 2022
Less than five per cent of adults across the eight major markets — the US, France, Germany, Italy, Spain, the UK, Japan, and China — with overactive bladder are currently managed with drug therapy...
Women, Take These Key Steps to Good Urological Health drugs
June 21, 2021
Women who try to hold their pee during the day might want to rethink that strategy.
Sheffield University gets £3.1 mn for trials to better bladder, prostate cancer diagnosis, treatment expresspharma
November 19, 2020
The two trials are part of a wider £8.3 million funding boost for new research programmes across Yorkshire.
Behavioral Therapy First Step for Overactive Bladder in Men drugs
January 14, 2020
Among men with overactive bladder, combined behavioral and drug therapy is superior to drug therapy alone, but not behavioral therapy alone, for symptomatic improvement, according to a study published online Jan. 13 in JAMA Internal Medicine.
Janssen’s bladder cancer drug Balversa receives FDA nod pharmaceutical-technology
April 22, 2019
Janssen Pharmaceutical has received the US Food and Drug Administration (FDA) approval for the drug Balversa (erdafitinib) to treat adults with locally advanced or metastatic urothelial carcinoma (mUC).
FDA approves first targeted therapy for metastatic bladder cancer worldpharmanews
April 16, 2019
FDA approves first targeted therapy for metastatic bladder cancer.